The R-Ras GTPase mediates cross talk between estrogen and insulin signaling in breast cancer cells

Molecular and Cellular Biology

Volumn 26, Issue 17, 2006, Pages 6372-6380

  Yu, Yi ^a   Hao, Yansheng ^a   Feig, Larry A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CALPAIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; GLUCOSE; GUANOSINE TRIPHOSPHATASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTEGRIN; MUTANT PROTEIN; PROTEIN BCAR3; PROTEIN R RAS38V; R RAS PROTEIN; RAS PROTEIN; REGULATOR PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; VALINE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRAIN ZR75; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; HUMAN CELL; INSULIN TREATMENT; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BREAST NEOPLASMS; CALPAIN; DOWN-REGULATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INSULIN; MICE; PHOSPHOPROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS; RAS PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 33747754138     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00509-05     Document Type: Article

References (34)

1. Arteaga, C. L., E. Coronado, and C. K. Osborne. 1988. Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer. Mol. Endocrinol. 2:1064-1069.
2. Boyd, D. B. 2003. Insulin and cancer. Integr. Cancer Ther. 2:315-329.
3. Cai, D., L. K. Clayton, A. Smolyar, and A. Lerner. 1999. AND-34, a novel p130Cas-binding thymic stromal cell protein regulated by adhesion and inflammatory cytokines. J. Immunol. 163:2104-2112.
4. Chan, T. W., M. Pollak, and H. Huynh. 2001. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780. Clin. Cancer Res. 7:2545-2554.
5. Cox, A. D., T. R. Brtva, D. G. Lowe, and C. J. Der. 1994. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene 9:3281-3288.
6. Gotoh, T., D. Cai, X. Tian, L. A. Feig, and A. Lerner. 2000. p130Cas regulates the activity of AND-34, a novel Ral, Rap1 and R-Ras guanine nucleotide exchange factor. J. Biol. Chem. 275:30118-30123.
7. Gotoh, T., Y. Niino, M. Tokuda, O. Hatase, S. Nakamura, M. Matsuda, and S. Hattori. 1997. Activation of R-Ras by Ras-guanine nucleotide-releasing factor. J. Biol. Chem. 272:18602-18607.
8. Hankinson, S. E., W. C. Willett, G. A. Colditz, D. J. Hunter, D. S. Michaud, B. Deroo, B. Rosner, F. E. Speizer, and M. Pollak. 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351:1393-1396.
9. Kruger, R. P., J. Aurandt, and K. L. Guan. 2005. Semaphores command cells to move. Nat. Rev. Mol. Cell Biol. 6:789-800.
10. Cas by a novel mechanism that differs from integrins. Mol. Cell. Biol. 23:933-949.
11. Lee, A. V., J. L. Gooch, S. Oesterreich, R. L. Guler, and D. Yee. 2000. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition. Mol. Cell. Biol. 20:1489-1496.
12. Lee, A. V., J. G. Jackson, J. L. Gooch, S. G. Hilsenbeck, E. Coronado-Heinsohn, C. K. Osborne, and D. Yee. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol. Endocrinol. 13:787-796.
13. Marte, B. M., P. Rodriguez-Viciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr. Biol. 7:63-70.
14. Molloy, C. A., F. E. May, and B. R. Westley. 2000. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J. Biol. Chem. 275:12565-12571.
15. Morelli, C., C. Garofalo, M. Bartucci, and E. Surmacz. 2003. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene 22:4007-4016.
16. Nishigaki, M., K. Aoyagi, I. Danjoh, M. Fukaya, K. Yanagihara, H. Sakamoto, T. Yoshida, and H. Sasaki. 2005. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res. 65:2115-2124.
17. Nolan, M. K., L. Jankowska, M. Prisco, S. Xu, M. A. Guvakova, and E. Surmacz. 1997. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells. Int. J. Cancer 72:828-834.
18. Oertli, B., J. Han, B. M. Marte, T. Sethi, J. Downward, M. Ginsberg, and P. E. Hughes. 2000. The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function. Oncogene 19:4961-4969.
19. Oesterreich, S., P. Zhang, R. L. Guler, X. Sun, E. M. Curran, W. V. Welshons, C. K. Osborne, and A. V. Lee. 2001. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res. 61:5771-5777.
20. Ohba, Y., N. Mochizuki, S. Yamashita, A. M. Chan, J. W. Schrader, S. Hattori, K. Nagashima, and M. Matsuda. 2000. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J. Biol. Chem. 275:20020-20026.
21. Oinuma, I., Y. Ishikawa, H. Katoh, and M. Negishi. 2004. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305:862-865.
22. Pandini, G., R. Vigneri, A. Costantino, F. Frasca, A. Ippolito, Y. Fujita-Yamaguchi, K. Siddle, I. D. Goldfine, and A. Belfiore. 1999. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin. Cancer Res. 5:1935-1944.
23. Pollak, M., J. Costantino, C. Polychronakos, S. A. Blauer, H. Guyda, C. Redmond, B. Fisher, and R. Margolese. 1990. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J. Natl. Cancer Inst. 82:1693-1697.
24. Sachdev, D., and D. Yee. 2001. The IGF system and breast cancer. Endocr.-Relat. Cancer 8:197-209.
25. Salerno, M., D. Sisci, L. Mauro, M. A. Guvakova, S. Ando, and E. Surmacz. 1999. Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells. Int. J. Cancer 81:299-304.
26. Self, A. J., E. Caron, H. F. Paterson, and A. Hall. 2001. Analysis of R-Ras signalling pathways. J. Cell Sci. 114:1357-1366.
27. Stewart, A. J., M. D. Johnson, F. E. May, and B. R. Westley. 1990. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem. 265:21172-21178.
28. Takai, Y., T. Sasaki, and T. Matozaki. 2001. Small GTP-binding proteins. Physiol. Rev. 81:153-208.
29. Umayahara, Y., R. Kawamori, H. Watada, E. Imano, N. Iwama, T. Morishima, Y. Yamasaki, Y. Kajimoto, and T. Kamada. 1994. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:16433-16442.
30. van Agthoven, T., T. L. van Agthoven, A. Dekker, P. J. van der Spek, L. Vreede, and L. C. Dorssers. 1998. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 17:2799-2808.
31. Wang, B., J. X. Zou, B. Ek-Rylander, and E. Ruoslahti. 2000. R-Ras contains a proline-rich site that binds to SH3 domains and is required for integrin activation by R-Ras. J. Biol. Chem. 275:5222-5227.
32. Yenush, L., and M. F. White. 1997. The IRS-signalling system during insulin and cytokine action. Bioessays 19:491-500.
33. Yu, Y., and L. A. Feig. 2002. Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells. Oncogene 21:7557-7568.
34. Zhang, Z., K. Vuori, H. Wang, J. C. Reed, and E. Ruoslahti. 1996. Integrin activation by R-ras. Cell 85:61-69.